Core Insights - The article emphasizes the high prevalence of HPV infection among men in China and the importance of early prevention strategies [2][4][8] - It highlights the recent approval of HPV vaccines for males, marking a new era in immunization against HPV-related diseases [3][6] - The need for increased public awareness and education regarding male HPV vaccination is underscored, as many men are unaware of their susceptibility to HPV [4][5][7] Summary by Sections - **HPV Infection in Men** - High infection rates among men in China, with peaks in young and middle-aged groups [2] - HPV can lead to various cancers in men, including anal, penile, and oropharyngeal cancers, with increasing incidence rates [2][4] - **Vaccination Initiatives** - Two HPV vaccines are available for males: a four-valent vaccine for ages 9-26 and a nine-valent vaccine for ages 16-26 [3] - The introduction of male vaccination is part of a broader strategy to combat HPV-related diseases [3][6] - **Public Awareness and Education** - There is a significant gap in public knowledge regarding male HPV infection and vaccination [4] - Efforts are needed to dispel myths and promote the concept of "co-prevention" for both genders [4][5] - **International Practices and Recommendations** - Global evidence supports the inclusion of male vaccination in national immunization programs to reduce HPV transmission and related diseases [6][7] - Successful examples from countries like Australia demonstrate the effectiveness of gender-inclusive vaccination strategies [7] - **Strategic Recommendations** - Six major initiatives proposed for male HPV prevention include comprehensive strategies, enhanced health education, and innovative funding mechanisms [8][9] - Collaboration across departments and leveraging technology for data-driven decision-making are essential for effective implementation [9]